background
variou
kind
commerci
molecular
system
develop
fast
accur
detect
respiratori
virus
anyplex
tm
ii
design
simultan
detect
respiratori
virus
use
multiplex
pcr
coupl
toce
tm
technolog
object
compar
perform
cultur
seeplex
ace
determin
sensit
specif
studi
design
seven
hundr
thirti
respiratori
sampl
test
modifi
shell
vial
cultur
method
molecular
test
autom
nucleic
acid
extract
liquid
handl
system
use
microlab
nimbu
ivd
hamilton
usa
adopt
maxim
workflow
accuraci
perform
assay
determin
composit
refer
standard
result
two
hundr
one
sampl
sampl
posit
cultur
addit
posit
sensit
cultur
viru
test
follow
influenza
influenza
b
rsv
adenoviru
piv
virus
cover
cultur
sensit
follow
rhinoviru
coronaviru
coronaviru
metapneumoviru
bocaviru
enteroviru
overal
specif
cultur
seegen
conclus
assay
superior
cultur
method
promis
tool
patient
manag
public
health
epidemiolog
respiratori
viral
infect
one
lead
caus
morbid
mortal
rapid
accur
identif
viral
etiolog
critic
rule
nonvir
infect
initi
time
therapeut
intervent
limit
spread
infect
diagnos
viral
respiratori
tract
infect
made
gener
culturebas
method
use
cell
cultur
andor
detect
antigen
although
method
effect
often
complementari
disadvantag
cell
cultur
consid
gold
standard
take
time
detect
antigen
often
lack
sensit
specif
even
method
appli
simultan
sampl
still
found
neg
despit
clinic
evid
viral
respiratori
infect
molecular
techniqu
offer
quicker
turnaround
time
greater
analyt
sensit
allow
identif
strain
difficult
cultur
use
standard
method
clinic
laboratori
especi
multiplex
rtpcr
enabl
laboratorian
detect
panel
virus
simultan
maintain
excel
sensit
specif
sever
studi
demonstr
advantag
multiplex
pcr
includ
seeplex
ace
detect
seegen
seoul
korea
achiev
approv
ce
health
canada
kfda
sold
countri
europ
canada
asia
recent
anyplex
tm
ii
tag
oligonucleotid
cleavag
extens
toce
technolog
seegen
seoul
korea
develop
toce
assay
novel
approach
realtim
pcr
use
two
compon
pitcher
catcher
target
bound
pitcher
toce
assay
move
detect
point
target
sequenc
catcher
enabl
predict
analysi
melt
temperatur
catcher
duplex
offer
multiplex
realtim
pcr
capabl
compar
new
multiplex
rtpcr
wellknown
cultur
determin
sensit
specif
octob
may
nasopharyng
aspir
npa
sampl
npa
patient
consecut
collect
patient
acut
respiratori
infect
korea
univers
anam
hospit
seoul
korea
sampl
flock
nasopharyng
swab
transport
ml
utm
copan
murrieta
ca
usa
freshli
use
viru
cultur
seeplex
assay
anyplex
tm
ii
assay
seegen
korea
studi
approv
research
ethic
board
korea
univers
anam
hospit
patient
frozenfreshcel
rmix
cell
diagnost
hybrid
athen
ohio
provid
cryovial
ship
dri
ice
accord
manufactur
instruct
thaw
cell
dilut
plant
medium
deliv
well
plate
two
hundr
microlit
specimen
inocul
plate
centrifug
overnight
incub
cell
monolay
wash
phosphatebuff
salin
fix
aceton
stain
respiratori
viru
fluoresc
antibodi
pool
dfa
diagnost
hybrid
athen
ohio
virusspecif
fluoresc
note
viru
identif
perform
use
diagnost
hybrid
individu
monoclon
antibodi
presenc
three
cell
per
well
specif
applegreen
fluoresc
consid
posit
identif
initi
screen
neg
second
vial
examin
day
nucleic
acid
extract
l
npa
sampl
use
microlab
nimbu
ivd
hamilton
reno
nv
usa
starmag
viru
kit
seegen
korea
elut
l
elut
buffer
cdna
synthesi
carri
revertaid
tm
firtst
strand
cdna
sysnthesi
kit
fermenta
burlington
canada
accord
manufactur
suggest
method
sampl
test
respiratori
viru
detect
kita
b
c
seeplex
ace
detect
kit
seegen
korea
accord
manufactur
instruct
detect
amplif
product
coupl
capillari
electrophoresi
technolog
tape
system
ltd
loanhead
uk
rna
extract
l
npa
sampl
addit
l
bacteriophag
intern
control
anyplex
tm
ii
detect
seegen
use
microlab
nimbu
ivd
hamilton
usa
starmag
viru
kit
seegen
seoul
korea
autom
protocol
extract
rtpcr
pcr
setup
implement
use
nimbu
autom
liquid
handl
workstat
maxim
workflow
accuraci
intern
control
ad
specimen
work
exogen
control
check
whole
process
nucleic
acid
extract
rtpcr
cdna
synthesi
perform
cdna
synthesi
auto
mix
seegen
korea
extract
rna
respiratori
viru
detect
kita
b
anyplex
tm
ii
detect
seegen
korea
use
accord
manufactur
instruct
briefli
toce
assay
conduct
final
volum
l
use
realtim
thermocycl
biorad
hercul
ca
usa
reaction
catcher
melt
temperatur
analysi
cmta
perform
cool
reaction
mixtur
c
hold
c
heat
c
c
fluoresc
measur
continu
temperatur
rise
melt
peak
deriv
initi
fluoresc
f
versu
temperatur
curv
perform
assay
determin
composit
refer
standard
uncultiv
virus
compar
result
concord
consid
true
posit
without
sequenc
howev
result
discrep
singleplex
pcr
sequenc
specif
primer
perform
confirmatori
test
main
outcom
studi
sensit
specif
cultur
assay
analys
perform
use
spss
version
spss
chicago
il
usa
tabl
studi
rsv
rhinovirus
virus
commonli
associ
multipl
agent
infect
follow
adenoviru
metapneumoviru
coronaviru
tabl
studi
two
two
quadrupl
virus
infect
specimen
detect
assay
tripl
virus
infect
specimen
detect
alon
result
remain
repeat
test
singleplex
pcr
confirmatori
sequenc
analysi
tabl
show
overal
distribut
respiratori
viral
pathogen
indic
predomin
influenza
virus
rsv
hrv
also
show
coronaviru
metapneumoviru
adenoviru
account
respect
follow
enteroviru
bocaviru
around
studi
evalu
perform
novel
assay
assay
viral
cultur
assay
offer
good
sensit
detect
common
respiratori
viral
agent
influenza
b
piv
rsva
b
viral
cultur
show
low
sensit
adenoviru
assay
show
superior
sensit
vs
viral
cultur
demonstr
low
sensit
studi
twentyeight
advposit
specimen
detect
alon
confirmatori
sequenc
demonstr
nineteen
six
two
one
specimen
adenoviru
c
b
f
type
respect
previou
studi
evalu
four
commerci
multiplex
pcr
assay
perform
adenoviru
good
virus
assum
due
variou
serolog
type
adenoviru
addit
molecular
assay
detect
viral
pathogen
cultur
neg
sampl
overal
detect
rate
studi
similar
previou
report
chines
studi
base
nasopharyng
swab
present
detect
rate
target
respiratori
virus
canadian
studi
base
nasopharyng
swab
show
detect
rate
seegen
korean
studi
perform
respiratori
specimen
patient
show
detect
rate
target
respiratori
virus
canadian
studi
use
nasopharyng
specimen
demonstr
viral
cultur
limit
abil
detect
virus
rhinoviru
difficult
detect
viral
cultur
due
divers
serotyp
studi
detect
rhinovirus
cultur
neg
sampl
although
mpv
caus
lower
respiratori
diseas
similar
caus
rsv
difficult
detect
mpv
cell
cultur
due
select
given
coronaviru
human
bocaviru
recent
discov
detect
worldwid
sometim
associ
sever
respiratori
ill
help
take
care
patient
previous
undefin
fatal
respiratori
ill
advantag
pcrbase
assay
detect
coinfect
usual
miss
viral
cultur
literatur
detect
rate
multipl
infect
multiplex
pcr
assay
rang
wherea
similar
studi
result
gharabaghi
et
al
use
multiplex
pcr
report
two
three
four
virusesinfect
specimen
total
respiratori
specimen
respect
although
role
multipl
viral
agent
affect
clinic
cours
diseas
present
unknown
multipl
agent
may
clinic
signific
especi
immun
compromis
individu
assay
would
provid
clinician
better
infecti
statu
patient
cultur
result
effect
prevent
multipl
infect
recent
kim
et
al
compar
perform
xtag
show
similar
sensit
almost
target
virus
report
lower
sensit
rhinoviru
compar
might
caus
use
xtag
good
perform
rhinoviru
arbitr
influenza
b
sensit
respect
kim
et
al
higher
studi
respect
studi
three
case
influenza
b
cultur
posit
molecular
assay
neg
detect
seem
make
differ
sensit
influenza
b
case
influenza
posit
cultur
neg
proflu
assay
genprob
prodess
inc
waukesha
wi
report
two
site
mismatch
found
later
probe
use
target
sequenc
kind
mismatch
might
happen
influenza
b
case
market
price
countri
compar
mark
technic
advanc
made
introduct
toce
cmta
toce
bypass
need
directli
measur
target
employ
artifici
templat
defin
predict
catcher
sequenc
catcher
defin
assay
design
result
duplex
catcher
yield
distinct
predict
melt
profil
melt
temperatur
analysi
refer
cmta
therebi
toce
cmta
system
stabli
detect
multipl
target
singl
channel
furthermor
increas
number
target
singl
tube
major
challeng
sever
multiplex
rtpcr
system
quantif
multipl
viral
target
reaction
tube
recent
repeat
melt
temperatur
analysi
name
cycliccmta
introduc
upgrad
version
cycliccmta
come
quantifi
multipl
viral
target
repeat
melt
curv
analysi
three
preselect
cycl
limit
system
intern
control
facil
artifici
target
includ
pcr
mastermix
allow
valid
pcr
step
addit
bacteriophag
extract
allow
rtpcr
system
monitor
rna
extract
revers
transcript
step
conclus
novel
assay
increas
sensit
detect
respiratori
virus
viral
cultur
maintain
excel
specif
new
multiplex
pcr
assay
superior
detect
viral
target
includ
multipl
infect
era
emerg
viral
infect
assay
benefici
determin
patient
manag
public
health
epidemiolog
